The device was cleared for the market by the FDA in 2020, the company said Feb. 22. Implanet began promoting the device in late 2021 after it acquired French company Orthopaedic & Spine Development.
Implanet has sold more than 7,000 of the cervical plates.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
